Trifluorimetyylifenyylipiperatsiini (Finnish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Trifluorimetyylifenyylipiperatsiini" in Finnish language version.

refsWebsite

Global rank Finnish rank

4^th place

12^th place

3,070^th place

17^th place

2^nd place

10^th place

1semanticscholar.org

11^th place

2,329^th place

doi.org

dx.doi.org

Schep LJ, Slaughter RJ, Vale JA, Beasley DM, Gee P: The clinical toxicology of the designer "party pills" benzylpiperazine and trifluoromethylphenylpiperazine. Clin Toxicol, March 2011, 49. vsk, nro 3, s. 131–41. PubMed:21495881 doi:10.3109/15563650.2011.572076 S2CID:42491343

finlex.fi

nih.gov

pubchem.ncbi.nlm.nih.gov

Trifluorimetyylifenyylipiperatsiinin aineenvaihdunta (HTML) pubchem.ncbi.nlm.nih.gov. Viitattu 7.4.2023. (englanniksi)
Trifluorimetyylifenyylipiperatsiinin sivuvaikutukset (HTML) pubchem.ncbi.nlm.nih.gov. Viitattu 7.4.2023. (englanniksi)

ncbi.nlm.nih.gov

Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB (March 2005). "N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy')". Neuropsychopharmacology. 30 (3): 550–60. doi:10.1038/sj.npp.1300585. PMID 15496938. S2CID 24217984.
Robertson DW, Bloomquist W, Wong DT, Cohen ML (1992). "mCPP but not TFMPP is an antagonist at cardiac 5HT3 receptors". Life Sciences. 50 (8): 599–605. doi:10.1016/0024-3205(92)90372-V. PMID 1736030.

pubmed.ncbi.nlm.nih.gov

Schep LJ, Slaughter RJ, Vale JA, Beasley DM, Gee P: The clinical toxicology of the designer "party pills" benzylpiperazine and trifluoromethylphenylpiperazine. Clin Toxicol, March 2011, 49. vsk, nro 3, s. 131–41. PubMed:21495881 doi:10.3109/15563650.2011.572076 S2CID:42491343

semanticscholar.org

api.semanticscholar.org

Schep LJ, Slaughter RJ, Vale JA, Beasley DM, Gee P: The clinical toxicology of the designer "party pills" benzylpiperazine and trifluoromethylphenylpiperazine. Clin Toxicol, March 2011, 49. vsk, nro 3, s. 131–41. PubMed:21495881 doi:10.3109/15563650.2011.572076 S2CID:42491343